Detalhe da pesquisa
1.
DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages.
Immunity
; 55(8): 1386-1401.e10, 2022 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35931086
2.
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
; 140(21): 2228-2247, 2022 11 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36130297
3.
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.
Blood
; 136(2): 157-170, 2020 07 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32347921
4.
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.
Hematol Oncol
; 40(4): 491-504, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35368098
5.
MDS overlap disorders and diagnostic boundaries.
Blood
; 133(10): 1086-1095, 2019 03 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30670443
6.
Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation.
Blood
; 134(20): 1730-1744, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31434702
7.
Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndrome.
Cytotherapy
; 23(3): 236-241, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33279399
8.
In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden.
Cytotherapy
; 23(4): 320-328, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33262074
9.
Newly revised 2023 MDS response criteria.
Blood
; 141(17): 2035-2036, 2023 04 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37103953
10.
Advances in Personalized Therapeutic Approaches in Myelodysplastic Syndromes.
J Natl Compr Canc Netw
; 17(11.5): 1444-1447, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31766023
11.
Leveraging premalignant biology for immune-based cancer prevention.
Proc Natl Acad Sci U S A
; 113(39): 10750-8, 2016 09 27.
Artigo
Inglês
| MEDLINE | ID: mdl-27638202
12.
Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.
RNA
; 22(10): 1535-49, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27492256
13.
Implications of molecular genetic diversity in myelodysplastic syndromes.
Curr Opin Hematol
; 24(2): 73-78, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27875374
14.
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
Blood
; 126(1): 9-16, 2015 Jul 02.
Artigo
Inglês
| MEDLINE | ID: mdl-25931582
15.
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.
Blood
; 126(21): 2355-61, 2015 Nov 19.
Artigo
Inglês
| MEDLINE | ID: mdl-26429975
16.
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(1): 60-87, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28040720
17.
Recent developments in myelodysplastic syndromes.
Blood
; 124(18): 2793-803, 2014 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-25237199
18.
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.
Blood
; 124(17): 2705-12, 2014 Oct 23.
Artigo
Inglês
| MEDLINE | ID: mdl-25224413
19.
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
BMC Cancer
; 16: 652, 2016 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27538433
20.
Splicing Factor Mutations in Cancer.
Adv Exp Med Biol
; 907: 215-28, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27256388